FireRehab.com is dedicated to educating firefighters about the vital importance of rehabilitation in staying safe and healthy on the job. The term "rehabilitation" encompasses topics ranging from heat exhaustion and dehydration to screening and treatment for Carbon Monoxide (CO) poisoning, which is toxic and can have serious, lifelong health effects. This site contains valuable news, tips and training info aimed at helping you and your department stay informed about firefighter rehabilitation.
FireRehab.com is operated by FireRescue1.com and sponsored by Masimo, the manufacturer of Rad-57™, the first non-invasive way of measuring CO in the blood.
FireRescue1 is dedicated to serving the fire community by providing firefighters with the most complete range of information and resources available. In a profession where lives depend on thorough knowledge and training, it is vital that fire professionals have a single, comprehensive resource to keep them informed about the most current fire news and technology and help them easily locate timely research and analysis.
FireRescue1 is supported by the Praetorian Group, the proven leader in online public safety resources. The experience and resources of the Praetorian Group has yielded a trusted and reliable online environment for the exchange of information between firefighters and departments from across the Unites States and around the world.
Masimo (NASDAQ: MASI) develops innovative monitoring technologies that significantly improve patient care-helping solve "unsolvable" problems. In 1995, the company debuted Read-Through Motion and Low Perfusion pulse oximetry, known as Masimo SET, and with it virtually eliminated false alarms and increased pulse oximetry's ability to detect life-threatening events. Masimo SET is the most accurate and reliable pulse oximetry technology, clinically proven in more than 100 independent and objective studies to provide the most trustworthy SpO2 and pulse rate measurements even under the most difficult clinical conditions, including patient motion and low peripheral perfusion. In 2005, Masimo introduced Masimo Rainbow SET, a breakthrough noninvasive blood constituent monitoring platform that can measure many blood constituents that previously required invasive procedures. Rainbow SET continuously and noninvasively measures carboxyhemoglobin (SpCO) and methemoglobin (SpMet), pleth variability index (PVI), in addition to oxyhemoglobin (SpO2), perfusion index (PI) and pulse rate, allowing early detection and treatment of potentially life-threatening conditions. Founded in 1989, Masimo has the mission of "Improving Patient Outcomes and Reducing Cost of Care by Taking Noninvasive Monitoring to New Sites and Applications." Additional information about Masimo and its products may be found at www.masimo.com.